Kopran Ltd share price logo

Kopran Share Price

NSE: KOPRAN

BSE: 524280

Small Cap

Healthcare Sector

₹139.60

-3.27

(-2.29%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Kopran Stock Performance

as on November 17, 2025 at 1:39 pm IST

  • Day's Low

    Day's High

    ₹139.05
    ₹143.45
    downward going graph

    0.39%

    Downside

    2.76%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹139.05
    ₹293.9
    downward going graph

    0.39%

    Downside

    110.53%

    Upside

    downward going graph

Kopran share price movements today

Previous Close
₹142.87
Open
₹139.70
Volume
1.39L
Upper Circuit
₹171.44
Lower Circuit
₹114.29
Day's Low - High
₹139.05 - ₹143.45
52 Week Low - High
₹139.05 - ₹293.9

Kopran Historical Returns

1 Month Return
-13.98 %
3 Month Return
-9.14 %
1 Year Return
-36.13 %
3 Year Return
-4.05 %
5 Year Return
+ 17.88 %

Kopran Fundamentals

as on November 17, 2025 at 1:39 pm IST

Market Cap

₹689.86 Cr

Return on Equity (ROE)

6.33

PE Ratio (TTM)

39.14

Return on capital employed (ROCE)

8.54

Industry PE ratio

42.22

Beta (LTM)

1.28

P/B Ratio

1.96

Dividend Yield

1.71

PEG Ratio

-5.35

Quarterly Earnings Growth YOY

-234.42

EPS (TTM)

7.98

Sector

Pharmaceuticals

Book Value

107.35

Technical Analysis

Bearish

View Technical Analysis

Kopran Stock Valuation

as on November 17, 2025 at 1:39 pm IST

Kopran in the last 5 years

  • Overview

  • Trends

Lowest (3.00x)

March 24, 2020

Today (39.14x)

November 14, 2025

Industry (42.22x)

November 14, 2025

Highest (53.33x)

September 5, 2023

LowHigh

Today’s Price to Earnings Ratio: 39.14x

Kopran Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kopran with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Kopran Ltd image
Kopran Ltd
NA689.863.58%0.6238629
Walpar Nutritions Ltd image
Walpar Nutritions Ltd
NA41.6511.12%0.69271
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY18,023.2017.76%0.718367,234
Everest Organics Ltd image
Everest Organics Ltd
NA415.5618.05%0.00-2159
Venmax Drugs & Pharmaceuticals Ltd image
Venmax Drugs & Pharmaceuticals Ltd
NA15.1968.12%0.00-1NA
See all

Kopran Stock’s Investor Sentiment and Interest

Search interest for Kopran Ltd Stock has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-14% versus previous 30 day period

Kopran Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
158
148.88
117
152.59
158.92
186.08
139.44
151.56
166.24
172.36
135.22
117.91
Other Income
2.22
3.78
2.39
0.13
2.43
9.67
2.63
1
0.17
3.26
2.56
0.03
Total Income
160.22
152.66
119.39
152.72
161.35
195.75
142.06
152.56
166.41
175.62
137.77
117.93
Expenses
145.68
136.72
110.69
129.76
135.34
164.39
121.27
136.82
146.4
155.28
121.09
123.19
Operating Profit
12.32
12.16
6.31
22.83
23.58
21.69
18.17
14.74
19.84
17.08
14.13
-5.28
Operating Profit Margin %
7.8%
8.17%
5.39%
14.96%
14.84%
11.66%
13.03%
9.73%
11.93%
9.91%
10.45%
-4.48%
Profit Before Interest, Tax and Depreciation
14.54
15.94
8.7
22.96
26.01
31.36
20.79
15.73
20.01
20.35
16.69
-5.25
Interest
2.24
1.78
1.83
1.94
2.24
2.59
2.18
2.23
2.16
2.77
2.54
2.09
Depreciation
3.16
3.24
3.26
2.77
3.27
3.59
3.87
3.85
4
3.87
4.26
4.28
Profit Before Tax
9.14
10.92
3.61
18.25
20.5
25.18
14.74
9.65
13.85
13.71
9.89
-11.62
Tax Paid
2.19
2.88
0.83
4.48
4.72
6.55
3.64
2.26
3.46
4.03
2.44
-1.7
Profit After Tax
6.95
8.04
2.77
13.77
15.79
18.62
11.1
7.38
10.4
9.68
7.45
-9.92
Total Net profit including share of profit / Loss from associate company
6.95
8.04
2.77
13.77
15.79
18.62
11.1
7.38
10.4
9.68
7.45
-9.92
EPS
1.44
1.67
0.58
2.86
3.28
3.86
2.3
1.53
2.16
2.01
1.54
-2.06
Actual EPS
1.44
1.67
0.58
2.86
3.28
3.86
2.3
1.53
2.16
2.01
1.54
-2.06
Adjusted EPS
1.44
1.67
0.58
2.86
3.28
3.86
2.3
1.53
2.16
2.01
1.54
-2.06
Diluted EPS
1.44
1.67
0.58
2.85
3.28
3.85
2.3
1.53
2.15
2.01
1.54
-2.06

Kopran Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
318.71
314.71
357.9
359.5
491.81
477.52
550.99
614.59
629.6
Other Income
10.77
9.6
3.06
0.63
17.99
10.6
3.07
14.61
3.98
Total Income
329.48
324.3
360.96
360.13
509.8
488.13
554.05
629.2
633.59
Expenses
282.69
284.31
311.57
313.36
410.03
390.13
499.19
540.18
556.7
Operating Profit
36.02
30.4
46.33
46.14
81.78
87.39
51.8
74.41
72.9
Operating Profit Margin %
11.3%
9.66%
12.94%
12.83%
16.63%
18.3%
9.4%
12.11%
11.58%
Profit Before Interest, Tax and Depreciation
46.79
39.99
49.39
46.77
99.77
98
54.86
89.02
76.88
Interest
13.7
8.6
8.99
8.91
6.24
5.12
6.08
8.59
9.34
Depreciation
8.33
8.51
8.74
9.58
10.19
11.1
12.71
12.89
15.59
Profit Before Tax
24.76
22.88
31.66
28.28
83.34
81.78
36.07
67.54
51.95
Tax Paid
4.85
2.4
7.64
7.27
21.73
20.75
8.83
16.59
13.39
Profit After Tax
19.91
20.49
24.02
21.02
61.61
61.03
27.23
50.96
38.55
Total Net profit including share of profit / Loss from associate company
19.91
20.49
24.02
21.02
61.61
61.03
27.23
50.96
38.55
EPS
4.6
4.74
5.55
4.86
14.24
13.77
5.65
10.57
7.99
Actual EPS
4.6
4.74
5.55
4.86
14.24
13.77
5.65
10.57
7.99
Adjusted EPS
4.6
4.74
5.55
4.86
14.24
13.77
5.65
10.57
7.99
Diluted EPS
4.6
4.74
5.55
4.86
14.24
13.77
5.65
10.55
7.99

Kopran Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
28.63
15.87
25.77
25.41
31
59.95
-33.48
34.02
43.26
41.94
Cash Flow from Investing Activities
-9.07
-17.97
-10.98
-24.86
-12.51
-28.96
-84.13
-12.58
-43.55
-56.42
Cash Flow from Financing Activities
-19.34
1.97
-15.02
-0.59
-18.06
-34.58
122.82
-19.84
0.99
25.88
Net Cash Flow
0.22
-0.12
-0.22
-0.03
0.42
0.1
4.93
1.53
0.69
11.38

Kopran Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
44.3%
44.3%
44.49%
44.49%
44.49%
44.49%
44.49%
44.49%
44.46%
44.42%
44.42%
44.42%
DII
0.14%
0.14%
0.14%
0.35%
0.14%
1.2%
0.14%
0.22%
0%
0%
0%
0%
FII
0%
0%
0%
0%
0.48%
0.84%
0.68%
1.32%
0.86%
1.12%
0.76%
0.6%
Public
55.22%
55.15%
55.03%
54.77%
54.89%
53.47%
54.7%
53.97%
54.68%
54.45%
54.82%
54.98%
Total Outstanding Shares
4,82,10,605
4,82,10,605
4,82,10,605
4,82,10,605
4,82,10,605
4,82,10,605
4,82,10,605
4,82,10,605
4,82,49,405
4,82,85,605
4,82,85,605
4,82,85,605
Total Shareholders
42,034
41,567
44,038
53,791
51,636
50,850
51,492
57,154
60,560
58,652
60,194
62,222

Mutual Funds that own Kopran Stock

Check out the Mutual Funds with significant holdings in Kopran.

Funds
Holdings
Shares Held
Bandhan BSE Healthcare Index Fund Direct Growth
Bandhan BSE Healthcare Index Fund Direct Growth
0.03%
367

Kopran Corporate Actions

View detailed summary of the earnings and dividend history of Kopran.

  • Kopran Ltd Earnings Results

    Kopran Ltd’s net profit fell -234.42% since last year same period to ₹-9.92Cr in the Q2 2025-2026. On a quarterly growth basis, Kopran Ltd has generated -233.15% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Kopran Ltd Dividends May,2025

    In the quarter ending March 2025, Kopran Ltd has declared dividend of ₹3.00 per share on 15 May 2025 - translating a dividend yield of 4.20%.

    Read More about Dividends

Indices Featuring Kopran Stock

Check stock indices that include Kopran.

BSE Healthcare

₹44,865.58

0.48 (▲212.72%)

BSE Small-Cap

₹53,437.38

0.58 (▲306.7%)

Insights on Kopran Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 54.82% to 54.98% in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 135.4% return, outperforming this stock by 139.4%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 44.42% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 23.4% return, outperforming this stock by 59.5%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.76% to 0.60% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, KOPRAN stock has moved down by -11.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 10.4 Cr → -9.92 Cr (in ₹), with an average decrease of 87.7% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 175.62 Cr → 117.93 Cr (in ₹), with an average decrease of 18.0% per quarter

About Kopran Ltd

Kopran, a pharmaceutical company controlled by Parijat Enterprises and promoted by Somani group, came out with a public issue in Nov.92 to finance its backward integration project and expand its antibiotic facility. Its bulk drug plant is approved by the US FDA and UK regulatory authorities, and in 1995 they were awarded Quality Excellence award by Indian Drug Manufacturers Association. Kopran manufactures penicillin and amoxycillin and has collaborations with Germany, South Korea, US and Adac Laboratories.They launched new products for therapeutic groups like asthma, cardiology, diabetes and lifestyle and obtained approval from European Directorate for Quality of Medicines and UK MHRA. Furthermore, they increased their installed capacity of liquids by 3.00 lakhs of liters and tablets/capsules by 270 croresNos during 2001. They also had tied up with EMerck for comarketing a new antiinflammatory drug in India and subsequently launched Cholestat Atorvastatin. Kopran has a high growth rate in exports and has been ranked amongst the top few fastest growing companies in IndiaORG Marg June 2000.

Revenue: ₹117.91Cr as on September 2025 (Q2 FY26)
Net Profit: ₹-9.92Cr as on September 2025 (Q2 FY26)
Listing date: 01 Dec, 1994
Chairperson Name: Susheel Somani
OrganisationKopran Ltd
IndustryPharmaceuticals
CEOSusheel Somani
E-voting on sharesClick here to vote

FAQs

What is Kopran share price today?

Kopran share price today stands at ₹139.6 as on . Kopran share today touched a day high of ₹143.45 and a low of ₹139.05.

What is the 52 week high and 52 week low range for Kopran share?

Kopran touched a 52 week high of ₹293.9 and a 52 week low of ₹139.05. Kopran share price today i.e. is trending at ₹139.6, which is -52.50% down from its 52 week high and 0.40% up from its 52 week low.

What is Kopran's market capitalisation today?

Kopran market capitalisation is ₹689.86 Cr as on .

How to buy Kopran shares?

To buy Kopran shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for KOPRAN or Kopran Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Kopran shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Kopran trading volume today?

Kopran trading volume is 1.39L as on . This means that 1.39L shares of Kopran were bought and sold on the stock market during today's trading session.